| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |